Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study
Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2016.07.010
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 1, 2016
Authors
Publisher
Elsevier BV